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Introduction
Juvenile idiopathic arthritis (JIA) is the most common
rheumatologic disorder of childhood. It is a group of
diseases characterized by chronic synovitis, associated
with many extra-articular manifestations including pul-
monary involvement, usually in the systemic type.
Alterations of pulmonary function in JIA may be a
complication of the underlying disease or related to
treatment with methotrexate.
Numerous reports have documented the association of
rheumatoid arthritis and pulmonary abnormalities. Also,
methotrexate may cause severe adverse pulmonary side-
effects in adults with rheumatoid arthritis.
While respiratory function in adults with rheumatoid
arthritis has been extensively investigated, few studies
have been carried out in JIA children.
Objectives
To evaluate lung function in a cohort of Juvenile Idio-
pathic Arthritis (JIA) patients followed in a tertiary care
center.
Methods
Transversal study of consecutive JIA patients recruited
in a Pediatric Rheumatology Clinic, between December
2011 and March 2012. Clinical history and past medical
history were collected by using medical records and a
structured questionnaire. Lung function evaluation
included spirometry, carbon monoxide diffusing capacity
(DLCO) and sniff nasal inspiratory pressure (SNIF).
Laboratory workup included complete blood count,
ESR, CRP, ANA and RF.
Results
41 recruited patients had ages between 6 and 20 years
(average 11.8 ± 4.1), 23 (62.2%) were females. 4 were
lost to follow-up.
2 patients had weight <P5 and 2 with weight >P95,
1 had height <P5 and 5 with height >P95, the remaining
had adequate growth.
Disease duration was 62.4 ± 29.1 months from diagno-
sis. 17 (45.9%) had oligoarticular, 8 (21.6%) systemic and
6 (16.2%) polyarticular type.
31(83.3%) had no active synovitis, and only 2 (5.7%)
had 3 or more active joints. 60% patients were currently
on medication: 10 (28.6%) methotrexate, 3 (8.6%) sulfa-
salazine, 1 (2.9%) anti-TNF, 1 (2.9%) anti-IL1 and
2 (5.7%) methotrexate plus anti-TNF.
No patients had previous known lung disease or
respiratory symptoms. Lung function tests were mostly
normal: Forced Vital Capacity (FVC%) 97.9 ± 17.0,
Forced Expiratory Volume in 1 second (FEV1%) 104.2 ±
17.5, FEV1/FVC% 99.18 ± 12.2, Total Lung Capacity
(TLC%) 94.6 ± 14.5, Residual Volume (RV%) 130.5 ±
53.1, DLCO% 93.1 ± 14,2, SNIF 69.6 ± 26.5. Only 3
patients had lung function changes - 2 restrictive and 1
obstructive spirometry patterns, no patients had changes
in DLCO.
Conclusion
The low prevalence of lung function changes in our
cohort is in agreement with the literature. In contrast to
studies performed in adult rheumatoid arthritis patients,
in children with juvenile idiopathic arthritis impairment
of lung function seems to be a rare event.
The small sample size, the fact that most of the
patients were in remission, as well as the lack of a con-
trol group can contribute to the difficulty in interpreting
the results.
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Prospective follow-up of this cohort, particularly those
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